The finding that FasL release and FasL/Fas mediated long-term cytotoxicity are not inhibited in NK cells treated with fluvastatin, indicates that tumor cells can be killed also when perforin/granzyme release is impaired. The gene discussed is FASLG; the disease is neoplasm.